Journal ArticleOpen Access
Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Authors
Author Affiliations
University of Chittagong
Published InIn Silico Pharmacology
Year2020
Citations56
Abstract
Aspirin (Asp) is one of the most important and ancient member of nonsteroidal anti-inflammatory drugs (NSAID), commonly used in medication of fever, pain and inflammation. It can inhibit the synthesis of prostaglandin by blocking the cyclooxygenase (COX). Attempts have been taken to analyze aspirin together with some of its modified derivatives applying quantum mechanical calculations in order to compare their physicochemical and biochemical properties. Density functional theory (DFT) with B3LYP/6-31G (d, p) basis set has been employed to elucidate their thermal, molecular orbital, equilibrium geometrical properties in gas phase. Molecular docking and nonbonding interactions have been performed against human cyclooxygenase-2 protein 5F1A to investigate the binding affinity and mode(s) of newly designed aspirin derivatives. ADMET prediction has been utilized to…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.